Overall, PSMA expression in the neovasculature was observed in PTC (61%—134/220 patients), FTC (56%—43/77), MTC (83%—104/126), and anaplastic thyroid carcinoma (ATC) (63%—12/19). This evidence concerns the gene FOLH1 and medullary thyroid gland carcinoma.